Diagnostic Potential of the Salivary Biomarkers to Differentiate Statuses of Periodontitis
Launched by UNIVERSITY OF BAGHDAD · Feb 1, 2023
Trial Information
Current as of June 03, 2025
Unknown status
Keywords
ClinConnect Summary
Diagnosis of Periodontitis represents the backbone of a successful periodontal treatment since the entire treatment plan, prognosis, and maintenance directly depend on the quality and precision of periodontal diagnosis. Since periodontal diagnostics is still based on clinical and radiological parameters providing limited therapeutic guidance, biomarkers have been introduced for the first time within the new classification of periodontal and peri-implant conditions as a first step towards the adoption of precision medicine concepts in periodontology. Saliva, as part of oral fluids, is an opt...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Male and female systemically healthy patients.
- • 2. Body mass index ≤ 30.
- • 3. Have a minimum of 20 teeth with facial and lingual scorable surfaces.
- 4. Clinical criteria for periodontal health and periodontitis will be as follows :
- • 1. Healthy periodontium (Group A): BOP \<10%, PPD ≤ 3mm, intact periodontium (no probing attachment loss).
- • 2. Periodontitis groups are defined as : i. Interdental CAL is detectable at ≥2 non-adjacent teeth, or ii. Buccal or oral CAL ≥3 mm with pocketing \>3mm is detectable at ≥2teeth
- Exclusion Criteria:
- • 1. Patients who refused to participate in the study.
- • 2. Individuals with dental implants.
- • 3. Previous history of extensive periodontal therapy preceding 6 months or currently under active periodontal treatment.
- • 4. Patients receiving antibiotic treatment or immunosuppressant medication within the last 3 months
- • 5. Pregnant or lactating mothers.
- • 6. Any symptoms of recent acute illness, e.g., COVID-19.
- • 7. Tobacco use.
- • 8. Active orthodontic therapy
- • -
About University Of Baghdad
The University of Baghdad, a leading academic institution in Iraq, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on collaboration and interdisciplinary approaches, the university leverages its extensive network of experts and state-of-the-art facilities to conduct rigorous clinical studies. The institution aims to contribute valuable insights into various health conditions, fostering an environment of scientific inquiry and ethical research practices that ultimately enhance patient care and public health in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
zainab J Raheem, MSc
Principal Investigator
University of Baghdad
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials